Immunotherapy Plus Chemotherapy Versus Chemotherapy Alone as First-Line Treatment for Advanced Urothelial Cancer: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials

Mamede, Isadora; Escalante-Romero, Lorena; Celso, Davi S. Gonçalves; Reis, Pedro C. Abrahao; Dacoregio, Maria Inez; Alves, Ana Caroline; Stecca, Carlos

doi:10.1016/j.clgc.2024.102154

Clinical Genitourinary Cancer

2024

DOI: 10.1016/j.clgc.2024.102154

|View full text |Cite

Immunotherapy Plus Chemotherapy Versus Chemotherapy Alone as First-Line Treatment for Advanced Urothelial Cancer: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials

Isadora Mamede,

Lorena Escalante-Romero,

Davi S. Gonçalves Celso

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 27 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Milestone achieved: FDA approves nivolumab in combination with cisplatin and gemcitabine for metastatic urothelial carcinoma

Khaliq,

Sohail,

Younas

et al. 2024

Annals of Medicine &Amp; Surgery

View full text Add to dashboard Cite

Milestone achieved: FDA approves nivolumab in combination with cisplatin and gemcitabine for metastatic urothelial carcinoma

Khaliq,

Sohail,

Younas

et al. 2024

Annals of Medicine &Amp; Surgery

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Immunotherapy Plus Chemotherapy Versus Chemotherapy Alone as First-Line Treatment for Advanced Urothelial Cancer: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials

Cited by 1 publication

References 27 publications

Milestone achieved: FDA approves nivolumab in combination with cisplatin and gemcitabine for metastatic urothelial carcinoma

Milestone achieved: FDA approves nivolumab in combination with cisplatin and gemcitabine for metastatic urothelial carcinoma

Contact Info

Product

Resources

About